FDA approves new diabetes medicationBetter glycemic control may reduce diabetes damageMelissa Healy
To date, there have been no case reports showing the efficacy of the new FDA-approved medication, ubrogepant, showing a greater than 50% decrease in headache duration.CureusMaria A. ShamsiMedicine, Royal College of Surgeons in Ireland - Medical University of Bahrain (RCSI-MU...
(In regulatory parlance, “secondary indications” come after the primary indications granted when a drug is initially approved by the FDA.) Why does this matter? Because unless these “secondary indications” are more intensely studied, and the data reviewed and vetted by the FDA, physicians will...
FDA approves 1st new type of pain medication in decades ABC News' Dr. Tara Narula explains the FDA's approval of Journavx, a non-opioid medication. January 31, 2025 Additional Live Streams Live ABC News Live Live Man charged in drunk driving death of NHL player Johnny Gaudreau appears...
Crexont, approved by the FDA in August 2024, is an extended-release treatment for Parkinson's disease. It combines carbidopa and levodopa in a single capsule. This novel formulation includes both extended-release beads for a gradual release of levodopa and immediate-release granules of carbidopa ...
According to the U.S. Food and Drug Administration (FDA), a prescription medicine, which has already been approved for pain management, has been approved in a new medication formulation. The product is called Belbuca and it is a buprenorphine buccal film product (dissolvable medication) that pro...
The following drugs are FDA approved for the preventive treatment of migraine in adults. Emgality is also approved for the treatment of episodic cluster headache in adults. Drug Name FDA Approval Company Drug Class Dosage Form Administration Qulipta (atogepant) September 28, 2021 AbbVie Inc. ca...
The FDA has approved Cimzia for the treatment of Crohn's disease. Ms. Terrie is a clinical pharmacy writer based in Haymarket, Virginia. UCB Inc's Cimzia The FDA has approved Cimzia (certolizumabpegol) for the treatment ofadults with moderate-to-severe Crohn'sdisease.1Cimzia is indicated to...
The US FDA approved aducanumab in June 2021 on the basis of the data of the EMERGE and ENGAGE trials. Both trials presented evidence of an intermediate effect of the drug on biomarkers, indicating amyloid removal, which is likely linked to the clinical benefit of aducanumab. Further trials ...
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, called the trial results "very encouraging," but said the drug needs close scrutiny by the FDA. Accessing Lagevrio (molnupiravir) outside of the UK Molnupiravir is currently approved and available for UK ...